Clinical Trial Update: BVS Implantation in Patients With Variant Angina and MODerate Coronary Artery Disease [Phase 4]

View source ↗

Summary

A Phase 4 trial studying BVS implantation in patients with variant angina and moderate coronary artery disease was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angina Pectoris Variant

Drugs mentioned

• BVS

Snippet

Sponsor: Seung-Jung Park | Conditions: Angina Pectoris, Variant | Phase 4 | Status: WITHDRAWN